Bank of America Raises CME Group (NASDAQ:CME) Price Target to $219.00

CME Group (NASDAQ:CMEFree Report) had its price target increased by Bank of America from $200.00 to $219.00 in a report released on Wednesday,Benzinga reports. They currently have an underperform rating on the financial services provider’s stock.

Other equities analysts have also recently issued research reports about the stock. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Piper Sandler increased their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Royal Bank of Canada raised their price objective on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Barclays upped their target price on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Finally, Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a research report on Monday, March 10th. Four analysts have rated the stock with a sell rating, eight have given a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $241.53.

View Our Latest Analysis on CME

CME Group Trading Up 0.1 %

Shares of CME stock opened at $262.54 on Wednesday. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $267.91. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a 50 day simple moving average of $251.50 and a two-hundred day simple moving average of $236.71. The company has a market cap of $94.61 billion, a P/E ratio of 27.15, a PEG ratio of 6.76 and a beta of 0.53.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Research analysts forecast that CME Group will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group’s dividend payout ratio is presently 51.71%.

CME Group announced that its board has initiated a share buyback program on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company’s stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,076 shares of company stock worth $6,871,496 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

A number of institutional investors and hedge funds have recently made changes to their positions in CME. Vanguard Group Inc. raised its holdings in shares of CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock valued at $7,952,273,000 after acquiring an additional 326,623 shares in the last quarter. Geode Capital Management LLC raised its stake in CME Group by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider’s stock valued at $1,946,717,000 after purchasing an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Norges Bank purchased a new position in CME Group in the 4th quarter worth approximately $1,107,389,000. Finally, FIL Ltd grew its stake in CME Group by 1.5% in the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider’s stock worth $947,821,000 after buying an additional 61,908 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.